976 related articles for article (PubMed ID: 23995140)
1. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
[TBL] [Abstract][Full Text] [Related]
2. The potential ecotoxicological impact of pharmaceutical and personal care products on humans and freshwater, based on USEtox™ characterization factors. A Spanish case study of toxicity impact scores.
Ortiz de García S; García-Encina PA; Irusta-Mata R
Sci Total Environ; 2017 Dec; 609():429-445. PubMed ID: 28755593
[TBL] [Abstract][Full Text] [Related]
3. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain.
Ortiz de García S; Pinto Pinto G; García Encina P; Irusta Mata R
Sci Total Environ; 2013 Feb; 444():451-65. PubMed ID: 23287535
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
Liebig M; Moltmann JF; Knacker T
Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
[TBL] [Abstract][Full Text] [Related]
5. PBT assessment and prioritization of contaminants of emerging concern: Pharmaceuticals.
Sangion A; Gramatica P
Environ Res; 2016 May; 147():297-306. PubMed ID: 26921826
[TBL] [Abstract][Full Text] [Related]
6. Emerging chemicals of concern: pharmaceuticals and personal care products (PPCPs) in Asia, with particular reference to Southern China.
Richardson BJ; Lam PK; Martin M
Mar Pollut Bull; 2005 Sep; 50(9):913-20. PubMed ID: 16038943
[TBL] [Abstract][Full Text] [Related]
7. Ecotoxicity and environmental risk assessment of pharmaceuticals and personal care products in aquatic environments and wastewater treatment plants.
Ortiz de García SA; Pinto Pinto G; García-Encina PA; Irusta-Mata R
Ecotoxicology; 2014 Oct; 23(8):1517-33. PubMed ID: 25064485
[TBL] [Abstract][Full Text] [Related]
8. A review of personal care products in the aquatic environment: environmental concentrations and toxicity.
Brausch JM; Rand GM
Chemosphere; 2011 Mar; 82(11):1518-32. PubMed ID: 21185057
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
10. Experiences with the OECD 308 transformation test: a human pharmaceutical perspective.
Ericson JF; Smith RM; Roberts G; Hannah B; Hoeger B; Ryan J
Integr Environ Assess Manag; 2014 Jan; 10(1):114-24. PubMed ID: 23794155
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals and personal care products in the aquatic environment in China: a review.
Bu Q; Wang B; Huang J; Deng S; Yu G
J Hazard Mater; 2013 Nov; 262():189-211. PubMed ID: 24036145
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
13. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain).
Ginebreda A; Muñoz I; de Alda ML; Brix R; López-Doval J; Barceló D
Environ Int; 2010 Feb; 36(2):153-62. PubMed ID: 19931909
[TBL] [Abstract][Full Text] [Related]
14. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes.
Sui Q; Huang J; Deng S; Chen W; Yu G
Environ Sci Technol; 2011 Apr; 45(8):3341-8. PubMed ID: 21428396
[TBL] [Abstract][Full Text] [Related]
15. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
Besse JP; Garric J
Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
[TBL] [Abstract][Full Text] [Related]
16. Integrated Risk Index of Chemical Aquatic Pollution (IRICAP): case studies in Iberian rivers.
Fàbrega F; Marquès M; Ginebreda A; Kuzmanovic M; Barceló D; Schuhmacher M; Domingo JL; Nadal M
J Hazard Mater; 2013 Dec; 263 Pt 1():187-96. PubMed ID: 23810233
[TBL] [Abstract][Full Text] [Related]
17. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment.
Kosma CI; Lambropoulou DA; Albanis TA
Sci Total Environ; 2014 Jan; 466-467():421-38. PubMed ID: 23933429
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system.
Kumar A; Xagoraraki I
Sci Total Environ; 2010 Nov; 408(23):5972-89. PubMed ID: 20869754
[TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
20. Ecological screening indicators of stress and risk for the Llobregat river water.
López-Roldán R; Jubany I; Martí V; González S; Cortina JL
J Hazard Mater; 2013 Dec; 263 Pt 1():239-47. PubMed ID: 23911059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
